Table of Content

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview
4.1. Introduction
4.2. Prostate Health Market, by Region

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising aging population and increasing prevalence rate of benign prostatic hyperplasia and prostate cancer
5.1.1.2. Growing government’s initiatives for advancement in technology in diagnosis
5.1.1.3. Innovation in hormone therapy drugs and developments genomics and proteomics
5.1.2. Restraints
5.1.2.1. Side-effects associated with BPH medications
5.1.3. Opportunities
5.1.3.1. Increasing researches leading to development of new drugs like Rucaparib and Olaparib
5.1.3.2. Development of novel modality of therapy for prostate cancer
5.1.4. Challenges
5.1.4.1. Low awareness regarding prostate health
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework

6. Prostate Health Market, by Disease Type
6.1. Introduction
6.2. Benign Prostatic Hyperplasia
6.3. Prostate Cancer
6.4. Prostatitis

7. Prostate Health Market, by Therapy Type
7.1. Introduction
7.2. AR-Directed Therapies
7.3. Cytotoxic Agents
7.4. Hormone ADT
7.5. Poly (ADP-Ribose) Polymerase (PARP) Inhibitors

8. Prostate Health Market, by Drug Treatment Type
8.1. Introduction
8.2. 5-Alpha Reductase Inhibitors
8.3.1. Dutasteride
8.3.2. Finasteride
8.3. Alpha Blockers
8.4.1. Alfuzosin
8.4.2. Doxazosin
8.4.3. Silodosin
8.4.4. Tamsulosin

9. Americas Prostate Health Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States

10. Asia-Pacific Prostate Health Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam

11. Europe, Middle East & Africa Prostate Health Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom

12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.2. Market Share Analysis, By Key Player
12.3. Competitive Scenario Analysis, By Key Player

13. Competitive Portfolio
13.1. Key Company Profiles
13.1.1. Astellas Pharma Inc.
13.1.2. AstraZeneca PLC
13.1.3. Bayer AG
13.1.4. Bristol-Myers Squibb Company
13.1.5. Elekta AB
13.1.6. Eli Lilly and Company
13.1.7. F. Hoffmann-La Roche AG
13.1.8. Ferring Pharmaceuticals Inc.
13.1.9. GlaxoSmithKline PLC
13.1.10. Ipsen Limited
13.1.11. Merck & Co., Inc.
13.1.12. Novartis AG
13.1.13. Pfizer Inc.
13.1.14. Sanofi S.A.
13.1.15. Takeda Pharmaceutical Company Ltd.
13.2. Key Product Portfolio

14. Appendix
14.1. Discussion Guide
14.2. License & Pricing



List of Figures

FIGURE 1. PROSTATE HEALTH MARKET RESEARCH PROCESS
FIGURE 2. PROSTATE HEALTH MARKET SIZE, 2023 VS 2030
FIGURE 3. PROSTATE HEALTH MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. PROSTATE HEALTH MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. PROSTATE HEALTH MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. PROSTATE HEALTH MARKET DYNAMICS
FIGURE 7. PROSTATE HEALTH MARKET SIZE, BY DISEASE TYPE, 2023 VS 2030 (%)
FIGURE 8. PROSTATE HEALTH MARKET SIZE, BY DISEASE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. PROSTATE HEALTH MARKET SIZE, BY THERAPY TYPE, 2023 VS 2030 (%)
FIGURE 10. PROSTATE HEALTH MARKET SIZE, BY THERAPY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. PROSTATE HEALTH MARKET SIZE, BY DRUG TREATMENT TYPE, 2023 VS 2030 (%)
FIGURE 12. PROSTATE HEALTH MARKET SIZE, BY DRUG TREATMENT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS PROSTATE HEALTH MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 14. AMERICAS PROSTATE HEALTH MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES PROSTATE HEALTH MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 16. UNITED STATES PROSTATE HEALTH MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC PROSTATE HEALTH MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC PROSTATE HEALTH MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA PROSTATE HEALTH MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA PROSTATE HEALTH MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. PROSTATE HEALTH MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 22. PROSTATE HEALTH MARKET SHARE, BY KEY PLAYER, 2023

List of Tables

TABLE 1. PROSTATE HEALTH MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018–2023
TABLE 3. PROSTATE HEALTH MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL PROSTATE HEALTH MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. PROSTATE HEALTH MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 6. PROSTATE HEALTH MARKET SIZE, BY BENIGN PROSTATIC HYPERPLASIA, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. PROSTATE HEALTH MARKET SIZE, BY PROSTATE CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. PROSTATE HEALTH MARKET SIZE, BY PROSTATITIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. PROSTATE HEALTH MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 10. PROSTATE HEALTH MARKET SIZE, BY AR-DIRECTED THERAPIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. PROSTATE HEALTH MARKET SIZE, BY CYTOTOXIC AGENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. PROSTATE HEALTH MARKET SIZE, BY HORMONE ADT, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. PROSTATE HEALTH MARKET SIZE, BY POLY (ADP-RIBOSE) POLYMERASE (PARP) INHIBITORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. PROSTATE HEALTH MARKET SIZE, BY DRUG TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 15. PROSTATE HEALTH MARKET SIZE, BY 5-ALPHA REDUCTASE INHIBITORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. PROSTATE HEALTH MARKET SIZE, BY 5-ALPHA REDUCTASE INHIBITORS, 2018-2030 (USD MILLION)
TABLE 17. PROSTATE HEALTH MARKET SIZE, BY DUTASTERIDE, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. PROSTATE HEALTH MARKET SIZE, BY FINASTERIDE, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. PROSTATE HEALTH MARKET SIZE, BY ALPHA BLOCKERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. PROSTATE HEALTH MARKET SIZE, BY ALPHA BLOCKERS, 2018-2030 (USD MILLION)
TABLE 21. PROSTATE HEALTH MARKET SIZE, BY ALFUZOSIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. PROSTATE HEALTH MARKET SIZE, BY DOXAZOSIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. PROSTATE HEALTH MARKET SIZE, BY SILODOSIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. PROSTATE HEALTH MARKET SIZE, BY TAMSULOSIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. AMERICAS PROSTATE HEALTH MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 26. AMERICAS PROSTATE HEALTH MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 27. AMERICAS PROSTATE HEALTH MARKET SIZE, BY DRUG TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 28. AMERICAS PROSTATE HEALTH MARKET SIZE, BY 5-ALPHA REDUCTASE INHIBITORS, 2018-2030 (USD MILLION)
TABLE 29. AMERICAS PROSTATE HEALTH MARKET SIZE, BY ALPHA BLOCKERS, 2018-2030 (USD MILLION)
TABLE 30. AMERICAS PROSTATE HEALTH MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 31. ARGENTINA PROSTATE HEALTH MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 32. ARGENTINA PROSTATE HEALTH MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 33. ARGENTINA PROSTATE HEALTH MARKET SIZE, BY DRUG TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 34. ARGENTINA PROSTATE HEALTH MARKET SIZE, BY 5-ALPHA REDUCTASE INHIBITORS, 2018-2030 (USD MILLION)
TABLE 35. ARGENTINA PROSTATE HEALTH MARKET SIZE, BY ALPHA BLOCKERS, 2018-2030 (USD MILLION)
TABLE 36. BRAZIL PROSTATE HEALTH MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 37. BRAZIL PROSTATE HEALTH MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 38. BRAZIL PROSTATE HEALTH MARKET SIZE, BY DRUG TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 39. BRAZIL PROSTATE HEALTH MARKET SIZE, BY 5-ALPHA REDUCTASE INHIBITORS, 2018-2030 (USD MILLION)
TABLE 40. BRAZIL PROSTATE HEALTH MARKET SIZE, BY ALPHA BLOCKERS, 2018-2030 (USD MILLION)
TABLE 41. CANADA PROSTATE HEALTH MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 42. CANADA PROSTATE HEALTH MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 43. CANADA PROSTATE HEALTH MARKET SIZE, BY DRUG TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 44. CANADA PROSTATE HEALTH MARKET SIZE, BY 5-ALPHA REDUCTASE INHIBITORS, 2018-2030 (USD MILLION)
TABLE 45. CANADA PROSTATE HEALTH MARKET SIZE, BY ALPHA BLOCKERS, 2018-2030 (USD MILLION)
TABLE 46. MEXICO PROSTATE HEALTH MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 47. MEXICO PROSTATE HEALTH MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 48. MEXICO PROSTATE HEALTH MARKET SIZE, BY DRUG TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 49. MEXICO PROSTATE HEALTH MARKET SIZE, BY 5-ALPHA REDUCTASE INHIBITORS, 2018-2030 (USD MILLION)
TABLE 50. MEXICO PROSTATE HEALTH MARKET SIZE, BY ALPHA BLOCKERS, 2018-2030 (USD MILLION)
TABLE 51. UNITED STATES PROSTATE HEALTH MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 52. UNITED STATES PROSTATE HEALTH MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 53. UNITED STATES PROSTATE HEALTH MARKET SIZE, BY DRUG TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 54. UNITED STATES PROSTATE HEALTH MARKET SIZE, BY 5-ALPHA REDUCTASE INHIBITORS, 2018-2030 (USD MILLION)
TABLE 55. UNITED STATES PROSTATE HEALTH MARKET SIZE, BY ALPHA BLOCKERS, 2018-2030 (USD MILLION)
TABLE 56. UNITED STATES PROSTATE HEALTH MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 57. ASIA-PACIFIC PROSTATE HEALTH MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 58. ASIA-PACIFIC PROSTATE HEALTH MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 59. ASIA-PACIFIC PROSTATE HEALTH MARKET SIZE, BY DRUG TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 60. ASIA-PACIFIC PROSTATE HEALTH MARKET SIZE, BY 5-ALPHA REDUCTASE INHIBITORS, 2018-2030 (USD MILLION)
TABLE 61. ASIA-PACIFIC PROSTATE HEALTH MARKET SIZE, BY ALPHA BLOCKERS, 2018-2030 (USD MILLION)
TABLE 62. ASIA-PACIFIC PROSTATE HEALTH MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 63. AUSTRALIA PROSTATE HEALTH MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 64. AUSTRALIA PROSTATE HEALTH MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 65. AUSTRALIA PROSTATE HEALTH MARKET SIZE, BY DRUG TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 66. AUSTRALIA PROSTATE HEALTH MARKET SIZE, BY 5-ALPHA REDUCTASE INHIBITORS, 2018-2030 (USD MILLION)
TABLE 67. AUSTRALIA PROSTATE HEALTH MARKET SIZE, BY ALPHA BLOCKERS, 2018-2030 (USD MILLION)
TABLE 68. CHINA PROSTATE HEALTH MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 69. CHINA PROSTATE HEALTH MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 70. CHINA PROSTATE HEALTH MARKET SIZE, BY DRUG TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 71. CHINA PROSTATE HEALTH MARKET SIZE, BY 5-ALPHA REDUCTASE INHIBITORS, 2018-2030 (USD MILLION)
TABLE 72. CHINA PROSTATE HEALTH MARKET SIZE, BY ALPHA BLOCKERS, 2018-2030 (USD MILLION)
TABLE 73. INDIA PROSTATE HEALTH MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 74. INDIA PROSTATE HEALTH MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 75. INDIA PROSTATE HEALTH MARKET SIZE, BY DRUG TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 76. INDIA PROSTATE HEALTH MARKET SIZE, BY 5-ALPHA REDUCTASE INHIBITORS, 2018-2030 (USD MILLION)
TABLE 77. INDIA PROSTATE HEALTH MARKET SIZE, BY ALPHA BLOCKERS, 2018-2030 (USD MILLION)
TABLE 78. INDONESIA PROSTATE HEALTH MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 79. INDONESIA PROSTATE HEALTH MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 80. INDONESIA PROSTATE HEALTH MARKET SIZE, BY DRUG TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 81. INDONESIA PROSTATE HEALTH MARKET SIZE, BY 5-ALPHA REDUCTASE INHIBITORS, 2018-2030 (USD MILLION)
TABLE 82. INDONESIA PROSTATE HEALTH MARKET SIZE, BY ALPHA BLOCKERS, 2018-2030 (USD MILLION)
TABLE 83. JAPAN PROSTATE HEALTH MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 84. JAPAN PROSTATE HEALTH MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 85. JAPAN PROSTATE HEALTH MARKET SIZE, BY DRUG TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 86. JAPAN PROSTATE HEALTH MARKET SIZE, BY 5-ALPHA REDUCTASE INHIBITORS, 2018-2030 (USD MILLION)
TABLE 87. JAPAN PROSTATE HEALTH MARKET SIZE, BY ALPHA BLOCKERS, 2018-2030 (USD MILLION)
TABLE 88. MALAYSIA PROSTATE HEALTH MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 89. MALAYSIA PROSTATE HEALTH MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 90. MALAYSIA PROSTATE HEALTH MARKET SIZE, BY DRUG TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 91. MALAYSIA PROSTATE HEALTH MARKET SIZE, BY 5-ALPHA REDUCTASE INHIBITORS, 2018-2030 (USD MILLION)
TABLE 92. MALAYSIA PROSTATE HEALTH MARKET SIZE, BY ALPHA BLOCKERS, 2018-2030 (USD MILLION)
TABLE 93. PHILIPPINES PROSTATE HEALTH MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 94. PHILIPPINES PROSTATE HEALTH MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 95. PHILIPPINES PROSTATE HEALTH MARKET SIZE, BY DRUG TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 96. PHILIPPINES PROSTATE HEALTH MARKET SIZE, BY 5-ALPHA REDUCTASE INHIBITORS, 2018-2030 (USD MILLION)
TABLE 97. PHILIPPINES PROSTATE HEALTH MARKET SIZE, BY ALPHA BLOCKERS, 2018-2030 (USD MILLION)
TABLE 98. SINGAPORE PROSTATE HEALTH MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 99. SINGAPORE PROSTATE HEALTH MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 100. SINGAPORE PROSTATE HEALTH MARKET SIZE, BY DRUG TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 101. SINGAPORE PROSTATE HEALTH MARKET SIZE, BY 5-ALPHA REDUCTASE INHIBITORS, 2018-2030 (USD MILLION)
TABLE 102. SINGAPORE PROSTATE HEALTH MARKET SIZE, BY ALPHA BLOCKERS, 2018-2030 (USD MILLION)
TABLE 103. SOUTH KOREA PROSTATE HEALTH MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 104. SOUTH KOREA PROSTATE HEALTH MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 105. SOUTH KOREA PROSTATE HEALTH MARKET SIZE, BY DRUG TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 106. SOUTH KOREA PROSTATE HEALTH MARKET SIZE, BY 5-ALPHA REDUCTASE INHIBITORS, 2018-2030 (USD MILLION)
TABLE 107. SOUTH KOREA PROSTATE HEALTH MARKET SIZE, BY ALPHA BLOCKERS, 2018-2030 (USD MILLION)
TABLE 108. TAIWAN PROSTATE HEALTH MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 109. TAIWAN PROSTATE HEALTH MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 110. TAIWAN PROSTATE HEALTH MARKET SIZE, BY DRUG TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 111. TAIWAN PROSTATE HEALTH MARKET SIZE, BY 5-ALPHA REDUCTASE INHIBITORS, 2018-2030 (USD MILLION)
TABLE 112. TAIWAN PROSTATE HEALTH MARKET SIZE, BY ALPHA BLOCKERS, 2018-2030 (USD MILLION)
TABLE 113. THAILAND PROSTATE HEALTH MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 114. THAILAND PROSTATE HEALTH MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 115. THAILAND PROSTATE HEALTH MARKET SIZE, BY DRUG TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 116. THAILAND PROSTATE HEALTH MARKET SIZE, BY 5-ALPHA REDUCTASE INHIBITORS, 2018-2030 (USD MILLION)
TABLE 117. THAILAND PROSTATE HEALTH MARKET SIZE, BY ALPHA BLOCKERS, 2018-2030 (USD MILLION)
TABLE 118. VIETNAM PROSTATE HEALTH MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 119. VIETNAM PROSTATE HEALTH MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 120. VIETNAM PROSTATE HEALTH MARKET SIZE, BY DRUG TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 121. VIETNAM PROSTATE HEALTH MARKET SIZE, BY 5-ALPHA REDUCTASE INHIBITORS, 2018-2030 (USD MILLION)
TABLE 122. VIETNAM PROSTATE HEALTH MARKET SIZE, BY ALPHA BLOCKERS, 2018-2030 (USD MILLION)
TABLE 123. EUROPE, MIDDLE EAST & AFRICA PROSTATE HEALTH MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 124. EUROPE, MIDDLE EAST & AFRICA PROSTATE HEALTH MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 125. EUROPE, MIDDLE EAST & AFRICA PROSTATE HEALTH MARKET SIZE, BY DRUG TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 126. EUROPE, MIDDLE EAST & AFRICA PROSTATE HEALTH MARKET SIZE, BY 5-ALPHA REDUCTASE INHIBITORS, 2018-2030 (USD MILLION)
TABLE 127. EUROPE, MIDDLE EAST & AFRICA PROSTATE HEALTH MARKET SIZE, BY ALPHA BLOCKERS, 2018-2030 (USD MILLION)
TABLE 128. EUROPE, MIDDLE EAST & AFRICA PROSTATE HEALTH MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 129. DENMARK PROSTATE HEALTH MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 130. DENMARK PROSTATE HEALTH MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 131. DENMARK PROSTATE HEALTH MARKET SIZE, BY DRUG TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 132. DENMARK PROSTATE HEALTH MARKET SIZE, BY 5-ALPHA REDUCTASE INHIBITORS, 2018-2030 (USD MILLION)
TABLE 133. DENMARK PROSTATE HEALTH MARKET SIZE, BY ALPHA BLOCKERS, 2018-2030 (USD MILLION)
TABLE 134. EGYPT PROSTATE HEALTH MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 135. EGYPT PROSTATE HEALTH MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 136. EGYPT PROSTATE HEALTH MARKET SIZE, BY DRUG TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 137. EGYPT PROSTATE HEALTH MARKET SIZE, BY 5-ALPHA REDUCTASE INHIBITORS, 2018-2030 (USD MILLION)
TABLE 138. EGYPT PROSTATE HEALTH MARKET SIZE, BY ALPHA BLOCKERS, 2018-2030 (USD MILLION)
TABLE 139. FINLAND PROSTATE HEALTH MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 140. FINLAND PROSTATE HEALTH MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 141. FINLAND PROSTATE HEALTH MARKET SIZE, BY DRUG TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 142. FINLAND PROSTATE HEALTH MARKET SIZE, BY 5-ALPHA REDUCTASE INHIBITORS, 2018-2030 (USD MILLION)
TABLE 143. FINLAND PROSTATE HEALTH MARKET SIZE, BY ALPHA BLOCKERS, 2018-2030 (USD MILLION)
TABLE 144. FRANCE PROSTATE HEALTH MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 145. FRANCE PROSTATE HEALTH MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 146. FRANCE PROSTATE HEALTH MARKET SIZE, BY DRUG TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 147. FRANCE PROSTATE HEALTH MARKET SIZE, BY 5-ALPHA REDUCTASE INHIBITORS, 2018-2030 (USD MILLION)
TABLE 148. FRANCE PROSTATE HEALTH MARKET SIZE, BY ALPHA BLOCKERS, 2018-2030 (USD MILLION)
TABLE 149. GERMANY PROSTATE HEALTH MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 150. GERMANY PROSTATE HEALTH MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 151. GERMANY PROSTATE HEALTH MARKET SIZE, BY DRUG TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 152. GERMANY PROSTATE HEALTH MARKET SIZE, BY 5-ALPHA REDUCTASE INHIBITORS, 2018-2030 (USD MILLION)
TABLE 153. GERMANY PROSTATE HEALTH MARKET SIZE, BY ALPHA BLOCKERS, 2018-2030 (USD MILLION)
TABLE 154. ISRAEL PROSTATE HEALTH MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 155. ISRAEL PROSTATE HEALTH MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 156. ISRAEL PROSTATE HEALTH MARKET SIZE, BY DRUG TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 157. ISRAEL PROSTATE HEALTH MARKET SIZE, BY 5-ALPHA REDUCTASE INHIBITORS, 2018-2030 (USD MILLION)
TABLE 158. ISRAEL PROSTATE HEALTH MARKET SIZE, BY ALPHA BLOCKERS, 2018-2030 (USD MILLION)
TABLE 159. ITALY PROSTATE HEALTH MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 160. ITALY PROSTATE HEALTH MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 161. ITALY PROSTATE HEALTH MARKET SIZE, BY DRUG TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 162. ITALY PROSTATE HEALTH MARKET SIZE, BY 5-ALPHA REDUCTASE INHIBITORS, 2018-2030 (USD MILLION)
TABLE 163. ITALY PROSTATE HEALTH MARKET SIZE, BY ALPHA BLOCKERS, 2018-2030 (USD MILLION)
TABLE 164. NETHERLANDS PROSTATE HEALTH MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 165. NETHERLANDS PROSTATE HEALTH MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 166. NETHERLANDS PROSTATE HEALTH MARKET SIZE, BY DRUG TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 167. NETHERLANDS PROSTATE HEALTH MARKET SIZE, BY 5-ALPHA REDUCTASE INHIBITORS, 2018-2030 (USD MILLION)
TABLE 168. NETHERLANDS PROSTATE HEALTH MARKET SIZE, BY ALPHA BLOCKERS, 2018-2030 (USD MILLION)
TABLE 169. NIGERIA PROSTATE HEALTH MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 170. NIGERIA PROSTATE HEALTH MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 171. NIGERIA PROSTATE HEALTH MARKET SIZE, BY DRUG TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 172. NIGERIA PROSTATE HEALTH MARKET SIZE, BY 5-ALPHA REDUCTASE INHIBITORS, 2018-2030 (USD MILLION)
TABLE 173. NIGERIA PROSTATE HEALTH MARKET SIZE, BY ALPHA BLOCKERS, 2018-2030 (USD MILLION)
TABLE 174. NORWAY PROSTATE HEALTH MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 175. NORWAY PROSTATE HEALTH MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 176. NORWAY PROSTATE HEALTH MARKET SIZE, BY DRUG TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 177. NORWAY PROSTATE HEALTH MARKET SIZE, BY 5-ALPHA REDUCTASE INHIBITORS, 2018-2030 (USD MILLION)
TABLE 178. NORWAY PROSTATE HEALTH MARKET SIZE, BY ALPHA BLOCKERS, 2018-2030 (USD MILLION)
TABLE 179. POLAND PROSTATE HEALTH MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 180. POLAND PROSTATE HEALTH MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 181. POLAND PROSTATE HEALTH MARKET SIZE, BY DRUG TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 182. POLAND PROSTATE HEALTH MARKET SIZE, BY 5-ALPHA REDUCTASE INHIBITORS, 2018-2030 (USD MILLION)
TABLE 183. POLAND PROSTATE HEALTH MARKET SIZE, BY ALPHA BLOCKERS, 2018-2030 (USD MILLION)
TABLE 184. QATAR PROSTATE HEALTH MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 185. QATAR PROSTATE HEALTH MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 186. QATAR PROSTATE HEALTH MARKET SIZE, BY DRUG TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 187. QATAR PROSTATE HEALTH MARKET SIZE, BY 5-ALPHA REDUCTASE INHIBITORS, 2018-2030 (USD MILLION)
TABLE 188. QATAR PROSTATE HEALTH MARKET SIZE, BY ALPHA BLOCKERS, 2018-2030 (USD MILLION)
TABLE 189. RUSSIA PROSTATE HEALTH MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 190. RUSSIA PROSTATE HEALTH MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 191. RUSSIA PROSTATE HEALTH MARKET SIZE, BY DRUG TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 192. RUSSIA PROSTATE HEALTH MARKET SIZE, BY 5-ALPHA REDUCTASE INHIBITORS, 2018-2030 (USD MILLION)
TABLE 193. RUSSIA PROSTATE HEALTH MARKET SIZE, BY ALPHA BLOCKERS, 2018-2030 (USD MILLION)
TABLE 194. SAUDI ARABIA PROSTATE HEALTH MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 195. SAUDI ARABIA PROSTATE HEALTH MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 196. SAUDI ARABIA PROSTATE HEALTH MARKET SIZE, BY DRUG TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 197. SAUDI ARABIA PROSTATE HEALTH MARKET SIZE, BY 5-ALPHA REDUCTASE INHIBITORS, 2018-2030 (USD MILLION)
TABLE 198. SAUDI ARABIA PROSTATE HEALTH MARKET SIZE, BY ALPHA BLOCKERS, 2018-2030 (USD MILLION)
TABLE 199. SOUTH AFRICA PROSTATE HEALTH MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 200. SOUTH AFRICA PROSTATE HEALTH MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 201. SOUTH AFRICA PROSTATE HEALTH MARKET SIZE, BY DRUG TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 202. SOUTH AFRICA PROSTATE HEALTH MARKET SIZE, BY 5-ALPHA REDUCTASE INHIBITORS, 2018-2030 (USD MILLION)
TABLE 203. SOUTH AFRICA PROSTATE HEALTH MARKET SIZE, BY ALPHA BLOCKERS, 2018-2030 (USD MILLION)
TABLE 204. SPAIN PROSTATE HEALTH MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 205. SPAIN PROSTATE HEALTH MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 206. SPAIN PROSTATE HEALTH MARKET SIZE, BY DRUG TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 207. SPAIN PROSTATE HEALTH MARKET SIZE, BY 5-ALPHA REDUCTASE INHIBITORS, 2018-2030 (USD MILLION)
TABLE 208. SPAIN PROSTATE HEALTH MARKET SIZE, BY ALPHA BLOCKERS, 2018-2030 (USD MILLION)
TABLE 209. SWEDEN PROSTATE HEALTH MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 210. SWEDEN PROSTATE HEALTH MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 211. SWEDEN PROSTATE HEALTH MARKET SIZE, BY DRUG TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 212. SWEDEN PROSTATE HEALTH MARKET SIZE, BY 5-ALPHA REDUCTASE INHIBITORS, 2018-2030 (USD MILLION)
TABLE 213. SWEDEN PROSTATE HEALTH MARKET SIZE, BY ALPHA BLOCKERS, 2018-2030 (USD MILLION)
TABLE 214. SWITZERLAND PROSTATE HEALTH MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 215. SWITZERLAND PROSTATE HEALTH MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 216. SWITZERLAND PROSTATE HEALTH MARKET SIZE, BY DRUG TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 217. SWITZERLAND PROSTATE HEALTH MARKET SIZE, BY 5-ALPHA REDUCTASE INHIBITORS, 2018-2030 (USD MILLION)
TABLE 218. SWITZERLAND PROSTATE HEALTH MARKET SIZE, BY ALPHA BLOCKERS, 2018-2030 (USD MILLION)
TABLE 219. TURKEY PROSTATE HEALTH MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 220. TURKEY PROSTATE HEALTH MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 221. TURKEY PROSTATE HEALTH MARKET SIZE, BY DRUG TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 222. TURKEY PROSTATE HEALTH MARKET SIZE, BY 5-ALPHA REDUCTASE INHIBITORS, 2018-2030 (USD MILLION)
TABLE 223. TURKEY PROSTATE HEALTH MARKET SIZE, BY ALPHA BLOCKERS, 2018-2030 (USD MILLION)
TABLE 224. UNITED ARAB EMIRATES PROSTATE HEALTH MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 225. UNITED ARAB EMIRATES PROSTATE HEALTH MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 226. UNITED ARAB EMIRATES PROSTATE HEALTH MARKET SIZE, BY DRUG TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 227. UNITED ARAB EMIRATES PROSTATE HEALTH MARKET SIZE, BY 5-ALPHA REDUCTASE INHIBITORS, 2018-2030 (USD MILLION)
TABLE 228. UNITED ARAB EMIRATES PROSTATE HEALTH MARKET SIZE, BY ALPHA BLOCKERS, 2018-2030 (USD MILLION)
TABLE 229. UNITED KINGDOM PROSTATE HEALTH MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 230. UNITED KINGDOM PROSTATE HEALTH MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 231. UNITED KINGDOM PROSTATE HEALTH MARKET SIZE, BY DRUG TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 232. UNITED KINGDOM PROSTATE HEALTH MARKET SIZE, BY 5-ALPHA REDUCTASE INHIBITORS, 2018-2030 (USD MILLION)
TABLE 233. UNITED KINGDOM PROSTATE HEALTH MARKET SIZE, BY ALPHA BLOCKERS, 2018-2030 (USD MILLION)
TABLE 234. PROSTATE HEALTH MARKET, FPNV POSITIONING MATRIX, 2023
TABLE 235. PROSTATE HEALTH MARKET SHARE, BY KEY PLAYER, 2023
TABLE 236. PROSTATE HEALTH MARKET LICENSE & PRICING